Zhongtong Finance APP announced the mid-term performance of Yimaiyangguang (02522) in 2024, with revenue of approximately 0.414 billion yuan, a year-on-year decrease of 21.9%; gross profit of approximately 0.16 billion yuan, a year-on-year decrease of 15.4%; the company's net profit attributable to owners of the company for the period decreased by 91.1% to 3.836 million yuan; earnings per share were 0.011 yuan.

The announcement stated that the overall decline in revenue was mainly due to the slowdown in the purchasing needs of medical institutions, which resulted in a decrease in revenue from imaging solution services. However, the core imaging center services of the group remain relatively stable, maintaining a solid business foundation and continuing to develop new projects, even in the face of macroeconomic slowdown and the strong regulatory impact of the medical industry policy environment. The company believes that the overall demand for imaging services in the entire industry remains relatively stable, especially with the national development of the Thousand Counties Project and the update of equipment in grassroots medical institutions, both the imaging center and imaging solution services can effectively meet the needs of improving equipment and enhancing imaging services capabilities in grassroots medical institutions.

The decrease in net profit is mainly attributed to the negative impact of the macroeconomic slowdown and changes in market conditions, as well as the listing of the company's H shares on the main board of the Hong Kong Stock Exchange on June 7, 2024, which incurred expenses related to the listing.